CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress

Go back to CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
(NASDAQ: GDTC) Delayed: 0.90 --0 (-0%)
Previous Close $0.90    52 Week High
Open $0.89    52 Week Low
Day High $0.90    P/E N/A 
Day Low $0.86    EPS
Volume 5,407